Cargando…

A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)

Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Hirotake, Kato, Izumi, Mitsunaga, Kanako, Hara, Mayumi, Kodama, Takahiro, Kanazawa, Masaki, Terai, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209596/
https://www.ncbi.nlm.nih.gov/pubmed/30402404
http://dx.doi.org/10.5415/apallergy.2018.8.e37
_version_ 1783366925984727040
author Takai, Hirotake
Kato, Izumi
Mitsunaga, Kanako
Hara, Mayumi
Kodama, Takahiro
Kanazawa, Masaki
Terai, Masaru
author_facet Takai, Hirotake
Kato, Izumi
Mitsunaga, Kanako
Hara, Mayumi
Kodama, Takahiro
Kanazawa, Masaki
Terai, Masaru
author_sort Takai, Hirotake
collection PubMed
description Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication including tipepidine hibenzate, the patient presented with generalized erythema and urticaria, swollen face, coughing, wheezing and vomiting, together with hypotension and a decreased level of consciousness. To identify the culprit drug, we performed skin prick tests (SPTs) and oral drug provocation tests (DPTs). SPTs revealed a negative reaction for all drugs, but DPTs caused a positive reaction only for a full therapeutic dose of tipepidine hibenzate. Physicians need to consider tipepidine hibezate as a culprit drug when anaphylaxis occurs after taking anticough or common cold medication.
format Online
Article
Text
id pubmed-6209596
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-62095962018-11-06 A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin) Takai, Hirotake Kato, Izumi Mitsunaga, Kanako Hara, Mayumi Kodama, Takahiro Kanazawa, Masaki Terai, Masaru Asia Pac Allergy Case Report Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication including tipepidine hibenzate, the patient presented with generalized erythema and urticaria, swollen face, coughing, wheezing and vomiting, together with hypotension and a decreased level of consciousness. To identify the culprit drug, we performed skin prick tests (SPTs) and oral drug provocation tests (DPTs). SPTs revealed a negative reaction for all drugs, but DPTs caused a positive reaction only for a full therapeutic dose of tipepidine hibenzate. Physicians need to consider tipepidine hibezate as a culprit drug when anaphylaxis occurs after taking anticough or common cold medication. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2018-10-18 /pmc/articles/PMC6209596/ /pubmed/30402404 http://dx.doi.org/10.5415/apallergy.2018.8.e37 Text en Copyright © 2018. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Takai, Hirotake
Kato, Izumi
Mitsunaga, Kanako
Hara, Mayumi
Kodama, Takahiro
Kanazawa, Masaki
Terai, Masaru
A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title_full A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title_fullStr A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title_full_unstemmed A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title_short A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
title_sort pediatric case of anaphylactic shock induced by tipepidine hibenzate (asverin)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209596/
https://www.ncbi.nlm.nih.gov/pubmed/30402404
http://dx.doi.org/10.5415/apallergy.2018.8.e37
work_keys_str_mv AT takaihirotake apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT katoizumi apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT mitsunagakanako apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT haramayumi apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT kodamatakahiro apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT kanazawamasaki apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT teraimasaru apediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT takaihirotake pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT katoizumi pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT mitsunagakanako pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT haramayumi pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT kodamatakahiro pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT kanazawamasaki pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin
AT teraimasaru pediatriccaseofanaphylacticshockinducedbytipepidinehibenzateasverin